I don't think clinical trials run in NL are known for having lower standards. I have read that shortages in participants for clinical trials in the U.S. have presented bottlenecks, so perhaps that's a consideration. I have also read that clinical trials in Europe can cost less, so another consideration.
There have been reports of intellectual property risks with running clinical trials in India, so I supposed it's good to know that it's not being run there.
you really picked the wrong reason to sell. The Netherlands (NTR) are well respected for clinical trials. If I had a drug that I wanted to market only in the US, FDA would be fine. I believe (I haven't read this in a few years, it might have changed) that drugs approved by the FDA still require International Clinical Trials Registry Platform (ICTRP). Think of the DCC as the swiss watch maker of clinical trials. The NTR is advised by an external Advisory Board whose role is to advise on the scope, operation, accessibility, sustainability and (inter)national obligations of the NTR. The board currently consists of experts from Netherlands Organization for Health Research and Development (ZonMw), the Dutch Institute for Healthcare Improvement (CBO), the Dutch Federation of University Medical Centers (NFU), the Dutch association of Research-oriented pharmaceutical industry (NEFARMA), and the Dutch Cochrane Centre.
Think of the NTR as the Swiss watch makers of clinical trials. The world is a better place to sell your goods, as opposed to just one country.
I'm just saying something doesn't add up. When I found this detail out last night, I decided it was time to get out. I'd be curious if anyone can point to information to the contrary regarding a single trial location. For now, this is just way to risky and speculative.